Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 114
Filter
Add more filters

Publication year range
1.
Adv Exp Med Biol ; 1410: 7-11, 2023.
Article in English | MEDLINE | ID: mdl-36396927

ABSTRACT

Monkeypox is a global health issue caused by the monkeypox virus. It can spread from person to person through respiratory secretions, direct exposure to dermatological lesions of infected patients, or exposure to contaminated objects. It is more common in homosexual men, and most patients are asymptomatic. The gold standard for diagnosis is a real-time polymerase chain reaction. In the absence of testing facilities, clinicians rely upon detailed history to exclude other causes of fever with rashes. Initially, there is a prodrome phase of a few days, which is followed by the appearance of rashes. The dermatological manifestations are in the form of an exanthematous rash, which transforms through a macular, papular, and vesicular phase and disappears after crusting in approximately 3 weeks. There can be associated lymphadenopathy in these patients. Respiratory manifestations include nasal congestion and shortness of breath that may result in secondary bacterial infections. Additionally, patients can have neurological involvement in the form of encephalitis. Furthermore, ocular involvement can occur in the form of conjunctivitis, keratitis, and corneal ulceration. Other symptoms can include diarrhea, vomiting, myalgia, and backache. Since most patients do not require hospitalization, the approach to treatment is mainly vigilant monitoring, antiviral therapy, and management of associated complications.


Subject(s)
Mpox (monkeypox) , Mpox (monkeypox)/complications , Mpox (monkeypox)/diagnosis , Mpox (monkeypox)/physiopathology , Mpox (monkeypox)/therapy , Humans , Monkeypox virus/genetics , Monkeypox virus/isolation & purification , Monkeypox virus/pathogenicity , Exanthema/etiology , Exanthema/virology , Lymphadenopathy/etiology , Lymphadenopathy/virology , Dyspnea/etiology , Dyspnea/virology , Encephalitis/etiology , Encephalitis/virology , Conjunctivitis/etiology , Conjunctivitis/virology , Keratitis/etiology , Keratitis/virology , Corneal Ulcer/etiology , Corneal Ulcer/virology
2.
JAMA ; 327(22): 2231-2237, 2022 06 14.
Article in English | MEDLINE | ID: mdl-35699701

ABSTRACT

Importance: Acute infectious conjunctivitis is characterized by ocular redness and discharge, and is a common clinical entity. Evidence-based tools to aid the clinical diagnosis of viral vs bacterial conjunctivitis are lacking and may contribute to overprescribing of topical antibiotics. Objective: To determine the relative prevalence of viral vs bacterial conjunctivitis in adults and children, and to determine which symptoms or signs are suggestive of a viral vs bacterial etiology. Data Sources: A MEDLINE search (January 1946-March 2022) yielded 1891 articles. Included articles were rated using a quality score based on a modified Rational Clinical Examination grading system. Methodological quality levels 1 through 4 required a microbiological reference standard for diagnosis, whereas quality level 5 (the lowest quality) used a clinical reference standard for diagnosis. Study Selection: Consecutive series of patients presenting with acute infectious conjunctivitis and case series of viral or bacterial conjunctivitis alone. Thirty-two studies were included in a meta-analysis to determine prevalence and diagnostic accuracy measures; 27 used a microbiological reference standard for diagnosis and 5 used a clinical reference standard for diagnosis. Results: In studies involving children (5 studies; 881 patients; mean age, 4.7 years [age range, 1 month-18 years]), the prevalence of bacterial conjunctivitis was higher than viral conjunctivitis (71% vs 16%, respectively, P = .01). In the only study of adults (n = 207 patients; mean age, 25.7 years), the prevalence of viral conjunctivitis was higher than bacterial conjunctivitis (78% vs 16%, respectively, P < .001). For the primary analysis of level 1 (n = 6) and level 2 (n = 5) studies (1725 patients total), the clinical findings that best distinguished a viral etiology for conjunctivitis from a bacterial etiology included pharyngitis (sensitivity range, 0.55-0.58; specificity range, 0.89-0.94; positive likelihood ratio [LR] range, 5.4-9.9), preauricular lymphadenopathy (sensitivity range, 0.17-0.31; specificity range, 0.93-0.94; positive LR range, 2.5-5.6), and contact with another person with red eye (sensitivity, 0.18 [95% CI, 0.14-0.22]; specificity, 0.93 [95% CI, 0.90-0.95]; positive LR, 2.5 [95% CI, 1.6-3.7]). Mucopurulent ocular discharge (sensitivity, 0.76 [95% CI, 0.60-0.87); specificity, 0.66 [95% CI, 0.58-0.73]; positive LR, 2.1 [95% CI, 1.7-2.6]) and otitis media (sensitivity, 0.24 [95% CI, 0.20-0.29]; specificity, 0.91 [95% CI, 0.85-0.94]; positive LR, 2.5 [95% CI, 1.5-4.4]) were associated with the presence of bacterial conjunctivitis. Conclusions and Relevance: In this review, bacterial conjunctivitis was more common than viral conjunctivitis in children and viral conjunctivitis was more common than bacterial conjunctivitis in adults, although the prevalence estimates were based on limited evidence. Symptoms and signs associated with a higher likelihood of viral conjunctivitis in adults and children included concomitant pharyngitis, an enlarged preauricular node, and contact with another person with red eye, and signs associated with a higher likelihood of bacterial conjunctivitis included the presence of mucopurulent discharge and otitis media, but no single symptom or sign differentiated the 2 conditions with high certainty.


Subject(s)
Conjunctivitis, Bacterial , Conjunctivitis, Viral , Acute Disease , Adolescent , Adult , Bacterial Infections/diagnosis , Bacterial Infections/epidemiology , Child , Child, Preschool , Conjunctivitis/epidemiology , Conjunctivitis/microbiology , Conjunctivitis/virology , Conjunctivitis, Bacterial/complications , Conjunctivitis, Bacterial/diagnosis , Conjunctivitis, Bacterial/epidemiology , Conjunctivitis, Viral/diagnosis , Conjunctivitis, Viral/epidemiology , Humans , Infant , Pharyngitis/complications , Prevalence , Sensitivity and Specificity , Suppuration/complications
3.
Optom Vis Sci ; 98(5): 429-436, 2021 05 01.
Article in English | MEDLINE | ID: mdl-33973912

ABSTRACT

SIGNIFICANCE: This analysis and review demonstrate that, although emerging data indicate that the prevalence of severe acute respiratory coronavirus 2 (SARS-CoV-2) on the ocular surface and coronavirus disease 2019 (COVID-19) conjunctivitis is rare, the ocular surface remains of interest as a potential inoculation and transmission site for SARS-CoV-2. Continued safety precautions should be taken as more data become available.COVID-19, caused by SARS-CoV-2, is a novel, global pandemic that has infected millions and, up to this point, caused more than two million fatalities worldwide. The ocular surface has become of interest as a possible vector for transmission by acting as a direct inoculation site, being a conduit for the virus into the respiratory system or as a method of transmission from potentially infected conjunctiva or tears. The components necessary for SARS-CoV-2 to theoretically infect ocular tissues are present: binding receptors (angiotensin-converting enzyme 2 and cluster of differentiation 147) and mechanisms for cell entry (transmembrane protease serine 2 and cathepsin L). This meta-analysis of COVID-19 prevalence data indicates that SARS-CoV-2 RNA has been infrequently found in conjunctival samples when tested with reverse transcriptase-polymerase chain reaction. This review estimates the prevalence of SARS-CoV-2 on the ocular surface and prevalence of conjunctivitis in patients with laboratory-confirmed COVID-19. There is much to be learned regarding ocular tropism of SARS-CoV-2.


Subject(s)
COVID-19/epidemiology , Conjunctivitis/epidemiology , Reverse Transcriptase Polymerase Chain Reaction/methods , Angiotensin-Converting Enzyme 2/metabolism , COVID-19/complications , COVID-19 Nucleic Acid Testing , Conjunctiva/virology , Conjunctivitis/complications , Conjunctivitis/virology , Humans , Pandemics , Polymerase Chain Reaction , Prevalence , RNA, Viral/analysis , Tears/chemistry , Tears/virology
4.
Vestn Oftalmol ; 137(5. Vyp. 2): 331-339, 2021.
Article in Russian | MEDLINE | ID: mdl-34669345

ABSTRACT

The review presents data on damage to the organ of vision in patients recovered from the new coronavirus infection reflecting on the results obtained by various researchers from examining patients with varying severity of the disease, both during the active stage and after recovery. Possible ways of transmission of the infectious agent into the organ of vision were analyzed. The most common ocular manifestation of COVID-19 is conjunctivitis, while lesions of the retina and optic nerve were noted less often. The article also outlines the strategy for treatment and describes infection prevention measures for doctors and patients.


Subject(s)
COVID-19 , Conjunctivitis , Eye Diseases/virology , COVID-19/complications , Conjunctivitis/virology , Humans , Ophthalmology , SARS-CoV-2 , Post-Acute COVID-19 Syndrome
5.
Indian J Med Res ; 151(5): 411-418, 2020 May.
Article in English | MEDLINE | ID: mdl-32611912

ABSTRACT

Coronavirus disease 2019 (COVID-19) is caused by a highly contagious RNA virus termed as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Ophthalmologists are at high-risk due to their proximity and short working distance at the time of slit-lamp examination. Eye care professionals can be caught unaware because conjunctivitis may be one of the first signs of COVID-19 at presentation, even precluding the emergence of additional symptoms such as dry cough and anosmia. Breath and eye shields as well as N95 masks, should be worn while examining patients with fever, breathlessness, or any history of international travel or travel from any hotspot besides maintaining hand hygiene. All elective surgeries need to be deferred. Adults or children with sudden-onset painful or painless visual loss, or sudden-onset squint, or sudden-onset floaters or severe lid oedema need a referral for urgent care. Patients should be told to discontinue contact lens wear if they have any symptoms of COVID-19. Cornea retrieval should be avoided in confirmed cases and suspects, and long-term preservation medium for storage of corneas should be encouraged. Retinal screening is unnecessary for coronavirus patients taking chloroquine or hydroxychloroquine as the probability of toxic damage to the retina is less due to short-duration of drug therapy. Tele-ophthalmology and artificial intelligence should be preferred for increasing doctor-patient interaction.


Subject(s)
Coronavirus Infections/epidemiology , Coronavirus Infections/transmission , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Occupational Exposure/prevention & control , Occupational Health/standards , Ophthalmology , Pandemics , Pneumonia, Viral/epidemiology , Pneumonia, Viral/transmission , COVID-19 , Conjunctivitis/virology , Corneal Transplantation , Coronavirus Infections/complications , Coronavirus Infections/diagnosis , Humans , Ophthalmology/methods , Personal Protective Equipment , Pneumonia, Viral/complications , Pneumonia, Viral/diagnosis , Practice Guidelines as Topic , Risk Factors , Tears/virology , Telemedicine , Tissue and Organ Procurement/standards
6.
Zhonghua Yan Ke Za Zhi ; 56(8): 571-572, 2020 Aug 11.
Article in Zh | MEDLINE | ID: mdl-32283878

ABSTRACT

This article was published ahead of print on the official website of Chinese Journal of Ophthalmology on April 14, 2020. Currently, it is commonly reported that coronavirus disease 2019 (COVID-19) patients are associated with conjunctival congestion and other symptoms, and the transmission route and high-risk eye diseases and high-risk working status are speculated. Are conjunctival congestion and conjunctiva-related symptoms in patients with 2019 novel coronavirus definitely related to the novel coronavirus? Conjunctival congestion is one of the common clinical signs of various types of conjunctivitis. The symptoms and signs of conjunctivitis in COVID-19 patients may be attributed to a variety of factors. Therefore, conjunctival symptoms should not be linked to 2019 novel coronavirus without evidence. ( Chin J Ophthalmol, 2020, 56: 571-572).


Subject(s)
Conjunctiva/pathology , Conjunctivitis/virology , Coronavirus Infections/complications , Pneumonia, Viral/complications , Betacoronavirus , COVID-19 , Conjunctiva/virology , Humans , Pandemics , SARS-CoV-2
7.
Zhonghua Yan Ke Za Zhi ; 56(6): 433-437, 2020 Jun 11.
Article in Zh | MEDLINE | ID: mdl-32295324

ABSTRACT

This article was published ahead of print on the official website of Chinese Journal of Ophthalmology on April 16,2020. Objective: To screen for novel coronavirus related conjunctivitis among patients with coronavirus disease 2019. Methods: Prospective series case study. Eighty-one patients diagnosed as coronavirus disease 2019 in Guangxi Zhuang Autonomous Region People's Hospital were enrolled with ophthalmological consultation and screening for novel coronavirus related conjunctivitis, including the inquiring of eye symptoms and checking for conjunctivitis-related signs. Novel coronavirus nucleic acid testing of conjunctival swabs was performed on patients with clinical manifestations of conjunctivitis. Results: Only 3 of the 81 patients (3.70%) complained of eye discomfort, which appeared on day 16.67±9.29 after the diagnosis of coronavirus disease 2019. The eye signs were not typical of viral conjunctivitis. Novel coronavirus nucleic acid tests of conjunctival swabs were negative in both eyes. There was no evidence to support the diagnosis of novel coronavirus related conjunctivitis. The remaining 78 patients showed no clinical symptoms or signs of conjunctivitis. Conclusions: The occurrence of novel coronavirus related conjunctivitis may be low in patients with coronavirus disease 2019.(Chin J Ophthalmol, 2020, 56: 433-437).


Subject(s)
Conjunctivitis/virology , Coronavirus Infections/prevention & control , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Betacoronavirus , COVID-19 , China , Humans , Prospective Studies , SARS-CoV-2
8.
Vestn Oftalmol ; 136(4): 118-123, 2020.
Article in Russian | MEDLINE | ID: mdl-32779465

ABSTRACT

This paper describes possible clinical ocular manifestations of novel coronavirus infection COVID-19. Two clinical cases of conjunctivitis are examined. Due to the lack of ophthalmological approaches to the treatment of such patients, different management tactics are given based on the severity of local and systemic disease manifestations. Our research and practical management of these conditions showed the toxic and allergic nature of ocular surface manifestations in patients with COVID-19. Such cases are proposed to be treated similar to the conjunctivitis of "unclear origin" with components from antiviral and anti-allergic therapies.


Subject(s)
Conjunctivitis/virology , Coronavirus Infections/complications , Eye Diseases/virology , Pneumonia, Viral/complications , Betacoronavirus , COVID-19 , Humans , Pandemics , SARS-CoV-2
9.
Emerg Infect Dis ; 25(5): 865-874, 2019 05.
Article in English | MEDLINE | ID: mdl-31002065

ABSTRACT

Lassa virus (LASV), a hemorrhagic fever virus endemic to West Africa, causes conjunctivitis in patients with acute disease. To examine ocular manifestations of LASV, we histologically examined eyes from infected guinea pigs. In fatal disease, LASV immunostaining was most prominent in the anterior uvea, especially in the filtration angle, ciliary body, and iris and in and around vessels in the bulbar conjunctiva and peripheral cornea, where it co-localized with an endothelial marker (platelet endothelial cell adhesion molecule). Antigen was primarily associated with infiltration of T-lymphocytes around vessels in the anterior uvea and with new vessel formation at the peripheral cornea. In animals that exhibited clinical signs but survived infection, eyes had little to no inflammation and no LASV immunostaining 6 weeks after infection. Overall, in this model, LASV antigen was restricted to the anterior uvea and was associated with mild chronic inflammation in animals with severe disease but was not detected in survivors.


Subject(s)
Conjunctivitis/virology , Endothelium, Corneal/virology , Iritis/virology , Keratitis/virology , Lassa virus/physiology , Animals , Biopsy , Conjunctivitis/pathology , Disease Models, Animal , Endothelium, Corneal/pathology , Female , Guinea Pigs , Immunohistochemistry , Iritis/pathology , Keratitis/pathology , Male , Polymerase Chain Reaction , RNA, Viral
10.
J Med Virol ; 91(6): 1030-1035, 2019 06.
Article in English | MEDLINE | ID: mdl-30659635

ABSTRACT

OBJECTIVE: To compare and evaluate the sensitivity of a newly developed silver-amplified immunochromatography (SAI) kit with various immunochromatography (IC) kits for adenoviruses based on the detection limit (copies/test). METHODS: An SAI kit and four ophthalmic IC kits were evaluated. The detection limits of the five kits were determined using the limiting dilution method for 15 conjunctivitis-associated adenoviruses (adenoviruses 1, 2, 3, 4, 5, 7, 8, 11, 37, 53, 54, 56, 64, 81, and 85). The detection limits were presented as numerical values as determined by real-time polymerase chain reaction (PCR). RESULTS: The detection limit of the SAI kit for the adenovirus types ranged from 1.0 × 103 -5.0 × 10 4 copies/test (geometric mean, 4.7 × 10 3 ). SAI had a 10-250-fold lower detection limit than the four IC kits for all adenoviruses studied. There were also differences in detection limits among the adenovirus types for each kit. DISCUSSION: The detection limit of the SAI kit was drastically reduced because the silver-amplification reaction increased the color development sensitivity. The results revealed the high sensitivity of SAI for detecting adenoviruses and suggested its usefulness for conjunctivitis examination.


Subject(s)
Chromatography, Affinity/standards , Conjunctivitis/diagnosis , Conjunctivitis/virology , Reagent Kits, Diagnostic/standards , Silver/chemistry , Adenoviruses, Human/isolation & purification , Chromatography, Affinity/methods , Humans , Limit of Detection , Sensitivity and Specificity
11.
Clin Infect Dis ; 67(9): 1315-1319, 2018 10 15.
Article in English | MEDLINE | ID: mdl-29878209

ABSTRACT

Background: Measles vaccine failure was first described in 1972. Over the next 20 years, vaccine failure was extensively studied, but during the last 25 years few investigations have been performed. We describe the clinical characteristics of measles in previously vaccinated and unvaccinated patients in California. Methods: All confirmed measles cases reported to the California Department of Public Health from 1 January 2000 through 31 December 2015 were reviewed. Clinical characteristics (rates of hospitalization, cough, coryza, conjunctivitis, and fever) were compared between the previously unvaccinated, those who had had 1 dose of vaccine, and those who had had ≥2 doses of measles vaccine. Results: There were 232 confirmed measles cases in whom vaccination status was verified; 80% were unvaccinated, 9% had had 1 dose of measles vaccine, and 11% had had ≥2 doses of measles vaccine. Subjects who had had ≥2 doses of measles vaccine had lower rates of hospitalization, cough, coryza, conjunctivitis, and fever than subjects who had 1 dose of measles vaccine or who were unimmunized. Conclusions: Vaccine failure measles cases were less ill than cases that occurred in unvaccinated patients. Nevertheless, these cases still required the same amount of public health effort in tracing contacts as in cases who were unvaccinated.


Subject(s)
Measles Vaccine/administration & dosage , Measles/epidemiology , Vaccination/statistics & numerical data , California/epidemiology , Common Cold/epidemiology , Common Cold/virology , Conjunctivitis/epidemiology , Conjunctivitis/virology , Cough/epidemiology , Cough/virology , Disease Outbreaks/prevention & control , Fever/epidemiology , Fever/virology , Humans , Measles Vaccine/therapeutic use , Post-Exposure Prophylaxis , Public Health , Treatment Failure
12.
BMC Infect Dis ; 18(1): 135, 2018 03 20.
Article in English | MEDLINE | ID: mdl-29558885

ABSTRACT

BACKGROUND: Human adenovirus (HAdV)-associated acute conjunctivitis is a common infectious disease and causes significant morbidity among residents in Beijing, China. However, little is known about the epidemiology and type distribution of acute adenoviral conjunctivitis in Beijing. METHODS: Acute conjunctivitis surveillance was conducted in 18 hospitals in Beijing from July through October during 2011-2013. HAdVs were detected by PCR from eye swab and types were determined by partial hexon and fiber gene sequencing. Risk factors associated with adenoviral conjunctivitis were analyzed. RESULTS: Of 876 conjunctivitis cases, 349 (39.8%) were HAdV positive. HAdV detection was most common in conjunctivitis patients aged 18-40 years; patients with contact history with a conjunctivitis case; patients with specimen collected on days 4-6 post symptom onset and patients who worked in food service as catering attendants. Fifteen types were identified among adenoviral conjunctivitis cases. Five HAdV types (HAdV-4, - 37, - 53, - 64 and - 8) accounted for 81.1% of all adenoviral conjunctivitis cases. HAdV-37, - 4 and - 53 were the most common types associated with adenoviral conjunctivitis in 2011, 2012 and 2013, respectively. CONCLUSION: Multiple HAdV types were associated with acute conjunctivitis in Beijing. Predominant types associated with adenoviral conjunctivitis circulating in Beijing varied from year to year.


Subject(s)
Adenoviridae/isolation & purification , Conjunctivitis/etiology , Acute Disease , Adenoviridae/genetics , Adenovirus Infections, Human/complications , Adenovirus Infections, Human/epidemiology , Adenovirus Infections, Human/virology , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , China/epidemiology , Conjunctivitis/epidemiology , Conjunctivitis/virology , DNA, Viral/isolation & purification , DNA, Viral/metabolism , Female , Genotype , Humans , Infant , Infant, Newborn , Logistic Models , Male , Middle Aged , Polymerase Chain Reaction , Risk Factors , Young Adult
13.
Acta Paediatr ; 107(5): 774-779, 2018 05.
Article in English | MEDLINE | ID: mdl-29345007

ABSTRACT

AIM: Our aim was to study prospectively the aetiology of neonatal conjunctivitis in a population-based setting. METHODS: Altogether 173 neonates with clinical conjunctivitis aged on average 20 (SD 10) days were recruited from child welfare clinics in Oulu, Finland, in 2010-2015. Conjunctival specimens were collected from 167 neonates for multiplex polymerase chain reaction to detect 16 respiratory viruses, from 163 for polymerase chain reaction to detect Chlamydia trachomatis and Neisseria gonorrhoeae and from 160 for bacterial culture studies. The cases were followed up until the age of 18 months. RESULTS: Viral conjunctivitis was diagnosed in 8/167 (4.8%; 95% CI 2.1-9.2%), chlamydial or gonococcal conjunctivitis in 0/163 cases (0%; 95% CI 0-2.2%) and other bacterial conjunctivitis in 58/160 (36%; 95% CI 29-44%). Rhinovirus was found at the ocular site in 4/167 (2.4%) neonates, adenovirus in 3/167 (1.8%) and bocavirus in 1/167 (0.6%). The most commonly isolated bacteria included Staphylococcus aureus (16%), Moraxella catarrhalis (9.4%) and Streptococcus pneumoniae (3.1%). None of these pathogens was associated with the 4/173 (2.3%) cases later operated on for persistent nasolacrimal duct obstruction. CONCLUSION: Chlamydia trachomatis was a rare pathogen in neonatal conjunctivitis in a population-based setting, but respiratory viruses were detected more frequently than indicated earlier.


Subject(s)
Conjunctivitis/virology , Chlamydia trachomatis/isolation & purification , Humans , Infant, Newborn , Neisseria gonorrhoeae/isolation & purification , Prospective Studies
14.
J Med Virol ; 89(2): 304-312, 2017 02.
Article in English | MEDLINE | ID: mdl-27364564

ABSTRACT

Human adenoviruses (HAdVs) are common causes of conjunctivitis. This study describes the epidemiological features and characterizes by phylogenetic analysis HAdVs isolated from patients with conjunctivitis in Tunisia, North Africa. Data on out-patients presenting with conjunctivitis during 2 years (2012-2013) were analyzed. Conjunctival swabs obtained from 240 patients were assessed for the presence of HAdVs by PCR amplification on the fiber and hexon genes. Positive PCR products, together with those of nine viral isolates from previous years, were sequenced and analyzed phylogenetically. Conjunctivitis represented 11.5% of all reasons of consultations with a slight increase between mid-March and mid-June. Sixty-five percent of samples (n = 156) revealed positive by at least one PCR test. PCR amplification in the hexon gene was slightly more sensitive as compared to the fiber gene. Genotyping in the two genomic regions gave concordant results for almost all isolates. HAdV-D8 was the most predominant genotype (87.6%) and was detected continuously from 2000 to 2013. Minor co-circulating genotypes including HAdV-E4, HAdV-B3, HAdV-B55, and HAdV-D37 were identified; most of them were detected by amplification in the hexon gene. In conclusion, this work reports molecular data on adenoviral conjunctivitis from a region where such information is scarce and contributes to a better knowledge of the worldwide distribution of causative genotypes. It revealed a predominance and endemic circulation of HAdV-D8, a genotype that was mainly reported from epidemic keratoconjunctivitis. It shows that PCR amplification in two different genomic regions enhances the sensitivity of HAdV detection in clinical samples and the identification of minor genotypes. J. Med. Virol. 89:304-312, 2017. © 2016 Wiley Periodicals, Inc.


Subject(s)
Adenoviridae Infections/epidemiology , Adenoviridae Infections/virology , Adenoviridae/classification , Adenoviridae/genetics , Conjunctivitis/epidemiology , Conjunctivitis/virology , Genetic Variation , Adenoviridae/isolation & purification , Adolescent , Adult , Aged , Capsid Proteins/genetics , Child , Child, Preschool , Genotype , Humans , Male , Middle Aged , Molecular Epidemiology , Phylogeny , Retrospective Studies , Tunisia/epidemiology , Young Adult
15.
J Infect Dis ; 213(1): 57-60, 2016 Jan 01.
Article in English | MEDLINE | ID: mdl-26153408

ABSTRACT

A 3.5-year-old adult female rhesus macaque (Macaca mulatta) manifested swelling of the left upper eyelid and conjunctiva and a decline in clinical condition 18 days following intramuscular challenge with Ebola virus (EBOV; Kikwit-1995), after apparent clinical recovery. Histologic lesions with strong EBOV antigen staining were noted in the left eye (scleritis, conjunctivitis, and peri-optic neuritis), brain (choriomeningoencephalitis), stomach, proximal duodenum, and pancreas. Spleen, liver, and adrenal glands, common targets for acute infection, appeared histologically normal with no evidence of EBOV immunoreactivity. These findings may provide important insight for understanding sequelae seen in West African survivors of Ebola virus disease.


Subject(s)
Brain/pathology , Central Nervous System Viral Diseases/pathology , Conjunctivitis/pathology , Ebolavirus/isolation & purification , Hemorrhagic Fever, Ebola/pathology , Scleritis/pathology , Animals , Brain/virology , Central Nervous System Viral Diseases/etiology , Central Nervous System Viral Diseases/virology , Conjunctivitis/etiology , Conjunctivitis/virology , Disease Models, Animal , Female , Hemorrhagic Fever, Ebola/complications , Hemorrhagic Fever, Ebola/physiopathology , Macaca mulatta , Necrosis , Scleritis/etiology , Scleritis/virology
16.
MMWR Morb Mortal Wkly Rep ; 65(39): 1082-1085, 2016 Oct 07.
Article in English | MEDLINE | ID: mdl-27711041

ABSTRACT

Zika virus is an emerging mosquito-borne flavivirus that typically causes an asymptomatic infection or mild illness, although infection during pregnancy is a cause of microcephaly and other serious brain abnormalities. Guillain-Barré syndrome and other neurologic complications can occur in adults after Zika virus infection. However, there are few published reports describing postnatally acquired Zika virus disease among children. During January 2015-July 2016, a total of 158 cases of confirmed or probable postnatally acquired Zika virus disease among children aged <18 years were reported to CDC from U.S. states. The median age was 14 years (range = 1 month-17 years), and 88 (56%) were female. Two (1%) patients were hospitalized; none developed Guillain-Barré syndrome, and none died. All reported cases were travel-associated. Overall, 129 (82%) children had rash, 87 (55%) had fever, 45 (29%) had conjunctivitis, and 44 (28%) had arthralgia. Health care providers should consider a diagnosis of Zika virus disease in children who have an epidemiologic risk factor and clinically compatible illness, and should report cases to their state or local health department.


Subject(s)
Zika Virus Infection/diagnosis , Zika Virus Infection/transmission , Zika Virus/isolation & purification , Adolescent , Arthralgia/virology , Child , Child, Preschool , Conjunctivitis/virology , Exanthema/virology , Female , Fever/virology , Humans , Infant , Male , Pregnancy , Pregnancy Complications, Infectious/diagnosis , Time Factors , Travel , United States , Zika Virus Infection/therapy
17.
Curr Opin Ophthalmol ; 27(6): 538-544, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27585217

ABSTRACT

PURPOSE OF REVIEW: The world has witnessed the largest Ebola virus disease (EVD) epidemic in West Africa with an unprecedented number of infected individuals and survivors. Many systemic and ocular complications have been reported in survivors. Herein, we review the ophthalmic complications associated with Ebolavirus. RECENT FINDINGS: EVD causes ocular disease during acute infection and during convalescence. Acute patients manifest with conjunctivitis, subconjunctival hemorrhages, and acute vision loss of unclear cause. The most common complication during recovery is uveitis with live virus implicated in the pathogenesis in one case. SUMMARY: This epidemic has brought to surface the spectrum of medical complications in EVD survivors with ophthalmic disease being one of the most critical because of its impact on individual functional status and its long-term economic implications. Future studies and programs are needed to appropriately evaluate the spectrum of ophthalmic disease in this at-risk population.


Subject(s)
Eye Infections, Viral/virology , Hemorrhage/virology , Hemorrhagic Fever, Ebola/complications , Conjunctivitis/virology , Humans , Uveitis/virology , Vision Disorders/virology
SELECTION OF CITATIONS
SEARCH DETAIL